The association of deamidation of Bcl-xL and translocation of Bax to the mitochondria through activation of JNK in the induction of apoptosis by treatment with GSH-conjugated DXR

被引:20
作者
Asakura, Tadashi [1 ]
Maeda, Kazuhiro [1 ]
Omi, Hiroko [1 ]
Matsudaira, Hiroshi [1 ]
Ohkawa, Kiyoshi [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Biochem, Minato Ku, Tokyo 1058461, Japan
关键词
Bcl-xL deamidation; Bax; JNK; apoptosis; GSH-conjugated DXR;
D O I
10.3892/ijo_00000020
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
We investigated the induction of apoptosis via deamidation of Bcl-xL and translocation of Bax to the mitochondria by treatment with GSH-DXR. GSH-DXR treatment of HepG2 cells, which did not express GST P1-1, exhibited deamidation of Bcl-xL, and the degree of deamidation was related to the activation of caspase-3. Overexpression of GST P1-1 in HepG2 cells decreased both the Bcl-xL deamidation and caspase-3 activation induced by treatment with GSH-DXR. Bcl-xL deamidation and caspase-3 activation were also suppressed by co-treatment with SP600125, a specific inhibitor of JNK activity. Overexpression of wild-type Bcl-xL in HepG2 decreased GSH-DXR-induced apoptosis although deamidation was observed. However, expression of the deamidated mutant of Bcl-xL, in which aspartic acid was substituted for both arginine 52 and 66 (N52,66D-Bcl-xL), exhibited high sensitivity for the induction of apoptosis. Expression of the Bcl-xL mutant, in which alanine was substituted for both arginine 52 and 66 (N52,66A-Bcl-xL), suppressed deamidation and showed resistance to the induction of apoptosis by treatment with GSH-DXR. On the other hand, endogenous Bax and overexpressed Flag-Bax were localized in the cytosolic fraction of HepG2 cells. Treatment of the cells with GSH-DXR caused translocation of Flag-Bax to the mitochondrial fraction following the induction of apoptosis. The induced apoptosis was enhanced by the expression of Flag-Bax. Moreover, Flag-Bax was partly located in the mitochondrial fraction in N52,66D-Bcl-xL-expressed cells without the induction of apoptosis. Therefore, the induction of apoptosis by treatment of HepG2 with GSH-DXR was enhanced, thereby facilitating the release of cytochrome c by both deamidated inactivation of Bcl-xL and functional translocation of Bax to the mitochondria via JNK activation. Deamidation of Bcl-xL might be induced in order to translocate Bax to the mitochondria.
引用
收藏
页码:389 / 395
页数:7
相关论文
共 62 条
[1]
The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]
Adler V, 2004, ANN CLIN LAB SCI, V34, P35
[3]
Regulation of JNK signaling by GSTp [J].
Adler, V ;
Yin, ZM ;
Fuchs, SY ;
Benezra, M ;
Rosario, L ;
Tew, KD ;
Pincus, MR ;
Sardana, M ;
Henderson, CJ ;
Wolf, CR ;
Davis, RJ ;
Ronai, Z .
EMBO JOURNAL, 1999, 18 (05) :1321-1334
[4]
Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria [J].
Antonsson, B ;
Montessuit, S ;
Lauper, S ;
Eskes, R ;
Martinou, JC .
BIOCHEMICAL JOURNAL, 2000, 345 :271-278
[5]
Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells [J].
Antonsson, B ;
Montessuit, S ;
Sanchez, B ;
Martinou, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :11615-11623
[6]
Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate [J].
Asakura, T ;
Sawai, T ;
Hashidume, Y ;
Ohkawa, Y ;
Yokoyama, S ;
Ohkawa, K .
BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) :711-715
[7]
Chemotherapeutic agents that induce mitochondrial apoptosis [J].
Asakura, T ;
Ohkawa, K .
CURRENT CANCER DRUG TARGETS, 2004, 4 (07) :577-590
[8]
Suppression of GST-P by treatment with glutathione-doxorubicin conjugate induces potent apoptosis in rat hepatoma cells [J].
Asakura, T ;
Hashizume, Y ;
Tashiro, K ;
Searashi, Y ;
Ohkawa, K ;
Nishihira, J ;
Sakai, M ;
Shibasaki, T .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (02) :171-177
[9]
Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells [J].
Asakura, T ;
Takahashi, N ;
Takada, K ;
Inoue, T ;
Ohkawa, K .
ANTI-CANCER DRUGS, 1997, 8 (02) :199-203
[10]
Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells [J].
Asakura, T ;
Ohkawa, K ;
Takahashi, N ;
Takada, K ;
Inoue, T ;
Yokoyama, S .
BRITISH JOURNAL OF CANCER, 1997, 76 (10) :1333-1337